Product Information
PROCHLORPERAZINE 5 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1148 per EA under NDC 27241028601. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application on May 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241028601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROCHLORPERAZINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA218515FDA Approved
5/9/2024
TE Code
AB
On Market Since
5/9/2024
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 5 MG TABLET has been published 86 times since Feb 12, 2025, and over the history we have for it it has declined 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1148 per EA |
|---|---|
| All-time high | $0.1688 (Apr 16, 2025) |
| All-time low | $0.1130 (Jul 22, 2026) |
| 52-week high | $0.1520 |
| 52-week low | $0.1130 |
| Median price | $0.1457 |
| Average price | $0.1411 |
| Largest weekly change | -9.2% (Feb 18, 2026) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prochlorperazine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 5 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.1148 per EA (NDC 27241028601), effective Sep 30, 2026.
How has the price of PROCHLORPERAZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 5 MG TABLET has declined 24.4%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 5 MG TABLET?
Since Feb 12, 2025, the NADAC for PROCHLORPERAZINE 5 MG TABLET has ranged from a low of $0.1130 (Jul 22, 2026) to a high of $0.1688 (Apr 16, 2025), with a median of $0.1457 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 5 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROCHLORPERAZINE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PROCHLORPERAZINE 5 MG TABLET?
PROCHLORPERAZINE 5 MG TABLET (NDC 27241028601) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.